Drug information on Cytrosar (Cytarabine) from VHB Lifesciences Inc.

Medical Condition(s) for which Cytrosar may be prescribed

---

•   Most Common : Bone marrow suppression, loss of appetite, nausea, vomiting, diarrhea, mouth ulcer, fever and rash.

•   Central Nervous System : Headache, dizziness, seizures, drowsiness, depression, anxiety, coma, incoordination, speech disorder and vision loss.

•   Respiratory : Lung swelling and cough.

•   Musculoskeletal : Muscle pain, neck pain and muscle stiffness.

•   Genitourinary : Increased urinary retention.

•   Eye : Blurred vision.

•   Skin : Increased sweating.

IV/SC- The recommended dose is 100 mg/m²/day (days 1 to 7) or 100 mg/m² IV every 12 hours (days 1 to 7).

It comes as a solution for injection to be administered by a healthcare into the vein.

Hypersensitivity.

• Caution should be exercised in patients with history of liver and kidney dysfunction, severe infections, preexisting drug-induced bone marrow suppression, any allergy, who are taking other medications, children, during pregnancy and breast-feeding.

• It may cause drowsiness, do not drive a car or operate machinery while taking this medication.

• It may decrease platelet counts, which leads to severe bleeding; avoid injury or bruising.

• Monitor complete blood cell counts, liver and kidney functions regularly while taking this medication.

• Avoid drinking alcoholic beverages and citrus fruit juices.

Avoid excess dosage.

Store it at controlled room temperature (25°C).